JP2009527484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527484A5 JP2009527484A5 JP2008555417A JP2008555417A JP2009527484A5 JP 2009527484 A5 JP2009527484 A5 JP 2009527484A5 JP 2008555417 A JP2008555417 A JP 2008555417A JP 2008555417 A JP2008555417 A JP 2008555417A JP 2009527484 A5 JP2009527484 A5 JP 2009527484A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- zileuton
- composition according
- single crystal
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77557906P | 2006-02-21 | 2006-02-21 | |
| PCT/US2007/004488 WO2007098189A2 (en) | 2006-02-21 | 2007-02-21 | New crystal forms and pharmaceutical compositions of (+) -r-zileuton |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009527484A JP2009527484A (ja) | 2009-07-30 |
| JP2009527484A5 true JP2009527484A5 (cg-RX-API-DMAC7.html) | 2010-04-08 |
Family
ID=38437967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555417A Pending JP2009527484A (ja) | 2006-02-21 | 2007-02-21 | (+)−r−ジロートンの新規結晶形態および医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8003684B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2001861A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009527484A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007217770B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2642216A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098189A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8445437B2 (en) * | 2006-07-27 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| CA2674492A1 (en) * | 2007-01-05 | 2008-07-17 | Cornerstone Therapeutics Inc. | Method for the treatment of conditions associated with increased 5-lipoxygenase and/or leukotriene activity |
| WO2009045291A2 (en) * | 2007-09-28 | 2009-04-09 | The Brigham And Women's Hospital, Inc. | Mast cell stabilizers in the treatment of obesity |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| EP2747762B1 (en) * | 2011-08-23 | 2015-07-01 | Cornerstone Therapeutics Inc. | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| US9855243B2 (en) | 2013-10-30 | 2018-01-02 | Qurient Co., Ltd. | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
| KR101462474B1 (ko) * | 2013-10-30 | 2014-11-19 | 주식회사 큐리언트 | 질레우톤 크림 제형의 국소용 항염증 약학적 조성물 |
| KR20170012332A (ko) * | 2014-06-20 | 2017-02-02 | 아비라겐 테라퓨틱스, 인코포레이티드 | [2-[1-(6-메틸-3-피리다지닐)-4-피페리디닐]에톡시]-3-에톡시-1,2-벤즈이속사졸의 무수 결정성 유리 염기 형태 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US279263A (en) * | 1883-06-12 | Eobeet t | ||
| ES2059408T3 (es) * | 1987-02-10 | 1994-11-16 | Abbott Lab | Un proceso para la preparacion de un compuesto. |
| EP0697868A4 (en) * | 1993-05-10 | 1998-04-08 | Sepracor Inc | THERAPIES AND COMPOSITIONS USING OPTICALLY PURE (+) - ZILEUTON |
| JPH09500139A (ja) | 1993-07-14 | 1997-01-07 | スミスクライン・ビーチャム・コーポレイション | ヒドロキシルアミンの酸付加塩の合成法 |
-
2007
- 2007-02-21 EP EP07751259A patent/EP2001861A2/en not_active Ceased
- 2007-02-21 CA CA002642216A patent/CA2642216A1/en not_active Abandoned
- 2007-02-21 AU AU2007217770A patent/AU2007217770B2/en not_active Ceased
- 2007-02-21 EP EP11176982A patent/EP2409973A1/en not_active Withdrawn
- 2007-02-21 JP JP2008555417A patent/JP2009527484A/ja active Pending
- 2007-02-21 US US11/709,299 patent/US8003684B2/en not_active Expired - Fee Related
- 2007-02-21 WO PCT/US2007/004488 patent/WO2007098189A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230373955A1 (en) | Synthesis of omecamtiv mecarbil | |
| US10035802B2 (en) | Solid state forms of ibrutinib | |
| JP2013529647A5 (cg-RX-API-DMAC7.html) | ||
| JP2014515372A5 (cg-RX-API-DMAC7.html) | ||
| JP2019505568A5 (cg-RX-API-DMAC7.html) | ||
| WO2014152270A1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| JP2007514746A5 (cg-RX-API-DMAC7.html) | ||
| JP2011513485A5 (cg-RX-API-DMAC7.html) | ||
| JP6556293B2 (ja) | 純粋なニロチニブ及びその塩の調製のための方法 | |
| KR20190133726A (ko) | 6-(시클로프로판카르복스아미도)-4-((2-메톡시-3-(1-메틸-1H-1,2,4-트리아졸-3-일)페닐)아미노)-N-(메틸-d3)피리다진-3-카르복스아미드의 결정 형태 | |
| US10519117B2 (en) | Crystal forms of 6-bromo-3-hydroxy-2-pyrazinecarboxamide | |
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| CN104628679A (zh) | Bitopertin的新合成方法及其中间体 | |
| WO2024114106A1 (zh) | 一种甲磺草胺中间体的合成方法 | |
| JP2013541589A5 (cg-RX-API-DMAC7.html) | ||
| JP2009541438A5 (cg-RX-API-DMAC7.html) | ||
| CN103951601B (zh) | 2-乙酰基-1-吡咯啉的合成方法 | |
| CN105777617A (zh) | 色瑞替尼的合成中间体及其制备方法 | |
| US10774042B2 (en) | Crystalline forms of apremilast | |
| JP2018024683A (ja) | 逆転写酵素阻害剤の結晶形態 | |
| WO2012153225A1 (en) | Improved processes for obtaining high purity of dronedarone hydrochloride | |
| CN101896496B (zh) | 4-脱氧-4-氟-d-葡萄糖衍生物的制造方法 | |
| EP3374349A1 (en) | Process for the preparation of eltrombopag olamine | |
| JPWO2005058914A1 (ja) | オキサセフェムの結晶 | |
| CN114364380A (zh) | (s)-2-((2s,3r)-1-氨基-3-羟基-1-氧代丁烷-2-基)-1-氧代-2,5-二氮杂螺[3.4]辛烷-5-甲酸叔丁酯的固体形式及其制备方法 |